Cubist Systematic Strategies, LLC Baxter International Inc Put Options Transaction History

Cubist Systematic Strategies, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$32.85 - $40.26 $220,095 - $269,742	6,700 Added 66.34%	16,800 $637,000
Q2 2024 Aug 14, 2024	SELL	$32.87 - $43.55 $289,256 - $383,240	-8,800 Reduced 46.56%	10,100 $337,000
Q1 2024 May 15, 2024	SELL	$37.88 - $43.77 $1.6 Million - $1.85 Million	-42,300 Reduced 69.12%	18,900 $807,000
Q4 2023 Feb 14, 2024	SELL	$31.71 - $38.95 $28,539 - $35,055	-900 Reduced 1.45%	61,200 $2.37 Million
Q3 2023 Nov 14, 2023	SELL	$37.32 - $49.29 $3.92 Million - $5.18 Million	-105,000 Reduced 62.84%	62,100 $2.34 Million
Q2 2023 Aug 14, 2023	BUY	$39.98 - $47.68 $99,949 - $119,200	2,500 Added 1.52%	167,100 $7.61 Million
Q1 2023 May 15, 2023	BUY	$37.58 - $52.57 $2.85 Million - $3.98 Million	75,800 Added 85.36%	164,600 $6.68 Million
Q4 2022 Feb 14, 2023	BUY	$49.7 - $57.71 $2.26 Million - $2.63 Million	45,500 Added 105.08%	88,800 $4.53 Million
Q3 2022 Nov 14, 2022	BUY	$53.86 - $66.8 $2.12 Million - $2.63 Million	39,300 Added 982.5%	43,300 $2.33 Million
Q2 2022 Aug 15, 2022	BUY	$63.83 - $80.0 $255,320 - $320,000	4,000 New	4,000 $257,000

1,007

450M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.